Shanghai Universal Biotech Co (SZSE:301166) Accounts Payable & Accrued Expense : ¥100 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Shanghai Universal Biotech Co Accounts Payable & Accrued Expense?

Shanghai Universal Biotech Co's quarterly accounts payable & accrued expense increased from Sep. 2024 (¥127 Mil) to Dec. 2024 (¥142 Mil) but then declined from Dec. 2024 (¥142 Mil) to Mar. 2025 (¥100 Mil).

Shanghai Universal Biotech Co's annual accounts payable & accrued expense increased from Dec. 2022 (¥128 Mil) to Dec. 2023 (¥161 Mil) but then declined from Dec. 2023 (¥161 Mil) to Dec. 2024 (¥142 Mil).

Shanghai Universal Biotech Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Shanghai Universal Biotech Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Universal Biotech Co Accounts Payable & Accrued Expense Chart

Shanghai Universal Biotech Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

106.82

141.12

128.13

160.60

141.81

Shanghai Universal Biotech Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															141.36	137.31	126.75	141.81	100.16

Shanghai Universal Biotech Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Shanghai Universal Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Universal Biotech Co Ltd (SZSE:301166) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1690 Kongjiang Road, Room 1505, Yangpu District, Shanghai, CHN, 200082

Website

https://www.univ-bio.com

Shanghai Universal Biotech Co Ltd is a focused on antibodies and related products. It is a professional and comprehensive antibody suppliers and antibodies experts , and has a one-stop efforts to develop a life sciences service providers.

Executives

Leng Zhao Wen

Director

Shanghai Universal Biotech Co Headlines

No Headlines